GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Albert Labs International Corp (XCNQ:ABRT) » Definitions » PS Ratio

Albert Labs International (XCNQ:ABRT) PS Ratio : (As of Jun. 25, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Albert Labs International PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Albert Labs International's share price is C$0.02. Albert Labs International's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 was C$0.00. Hence, Albert Labs International's PS Ratio for today is .

The historical rank and industry rank for Albert Labs International's PS Ratio or its related term are showing as below:

XCNQ:ABRT's PS Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 8.75
* Ranked among companies with meaningful PS Ratio only.

Albert Labs International's Revenue per Sharefor the three months ended in Sep. 2023 was C$0.00. Its Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 was C$0.00.

Back to Basics: PS Ratio


Albert Labs International PS Ratio Historical Data

The historical data trend for Albert Labs International's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Albert Labs International PS Ratio Chart

Albert Labs International Annual Data
Trend Dec21 Dec22
PS Ratio
- -

Albert Labs International Quarterly Data
Mar21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Albert Labs International's PS Ratio

For the Biotechnology subindustry, Albert Labs International's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Albert Labs International's PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Albert Labs International's PS Ratio distribution charts can be found below:

* The bar in red indicates where Albert Labs International's PS Ratio falls into.



Albert Labs International PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Albert Labs International's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=0.02/0
=

Albert Labs International's Share Price of today is C$0.02.
Albert Labs International's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


Albert Labs International  (XCNQ:ABRT) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Albert Labs International PS Ratio Related Terms

Thank you for viewing the detailed overview of Albert Labs International's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Albert Labs International (XCNQ:ABRT) Business Description

Traded in Other Exchanges
N/A
Address
6996, Merritt Avenue, Burnaby, BC, CAN, V5J 4R6
Albert Labs International Corp is a laboratory-based, clinical research and drug development enterprise addressing mental health care needs. The company is focusing on Real World Evidence (RWE) the company will initially look to commercialize its mycelium-based KRN-101 medicine and treatment with the help of clinical pathway.

Albert Labs International (XCNQ:ABRT) Headlines

No Headlines